|  | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|
RoM | 95%CI | P value | RoM | 95%CI | P value | ||
Journal impact factor | (One unit) | 1.11 | [1.07–1.14] | <0.0001 | 1.10 | [1.07–1.12] | <0.0001 |
Study design | • RCT vs observational study | 1.02 | [0.78–1.32] | 0.9259 | 0.65 | [0.41–1.02] | 0.0593 |
• Phase I/II, non-randomized trial vs observational study | 0.46 | [0.34–0.62] | <0.0001 | 0.58 | [0.33–1.05] | 0.0715 | |
• SR/MA vs observational study | 0.97 | [0.70–1.34] | 0.8381 | 1.46 | [0.74–2.86] | 0.2724 | |
Abstract conclusion | In favour of study treatment (yes vs no) | 1.34 | [1.04–1.74] | 0.0254 | 0.97 | [0.60–1.58] | 0.9134 |
Funding source | Non-profit vs for profit | 1.30 | [0.97–1.73] | 0.0773 | 1.45 | [1.08–1.94] | 0.0126 |
Open access | Yes vs no | 1.72 | [1.27–2.33] | 0.0005 | 1.48 | [1.02–2.16] | 0.0418 |
Press release | Yes vs no | 11.61 | [6.78–19.87] | <0.0001 | 10.14 | [4.91–20.96] | <0.0001 |